Trial intelligence / Profile preview

Desloratadine vs Levocetirizine in Induced Allergic Rhinitis

NCT00789152Phase 3Completed

Sponsor
Organon & Co.
Start
Dec 2003
Primary completion
May 2004
Modality
Small Molecules
01

Overview

A Phase 3 trial of desloratadine in allergic rhinitis (AR), sponsored by Organon & Co.. Started Dec 2003; status: completed.

02

Drugs

desloratadine
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on NCT00789152.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00789152.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call